Day 2 – Wednesday 8 November
8-8.20 Registration
8.20-9.10 Industry satellite symposium
WHO Global Roadmap to Defeat Meningitis by 2030 – Chair: Professor Sir Brian Greenwood, LSHTM
9.10-9.35 Towards a world free of meningitis: progress of the WHO Global Roadmap to defeat meningitis by 2030– Antoine Durupt, WHO
9.35-10.00 Panel discussion - why the road map matters for research: Antoine Durupt, WHO; Professor Caroline Trotter, University of Cambridge; Dr Matt Coldiron, MRF
Prevention and epidemic control (1) – Chair: Professor James Stuart, University of Bristol
10.00-10.25 Invasive meningococcal disease in countries of the African meningitis belt: recent outbreaks, overview of MenAfriVac introduction and WHO SAGE recommendations for the introduction of MenACWYX - Dr Andre Bita, WHO
10.25-10.50 Global overview of infant and adolescent MenB programmes; current schedules and potential future use of MenABCWY vaccines - Professor Marco Safadi, Santa Casa de São Paulo School of Medicine, Brazil
10.50-11.20 COFFEE, EXHIBITIONS AND POSTERS
Prevention and epidemic control (2) – Chair: Professor Saul Faust, University of Southampton
11.20-11.45 Post-pandemic gonorrhoea: does this change the perspective for meningitis prevention? - Professor Calman MacLennan, University of Oxford
11.45-12.10 New approaches to developing MenB vaccines – Professor Christoph Tang, University of Oxford
Prevention and epidemic control (3) – Chair: Professor Paul Heath, SGUL
12.10-12.35 The future of GBS prevention: current status of vaccines and serocorrelates of protection - Dr Konstantinos Karampatsas, St George’s University of London
12.35-13.00 Preventing viral meningitis: what vaccines are in development? - Dr Seilesh Kadambari, Great Ormond Street Hospital, London
13.00-14.00 LUNCH, EXHIBITIONS AND POSTERS
Poster presentations from the top 5 poster abstracts and award for the best poster - Chair: Professor Robert Heyderman, UCL
14.00-14.06 Poster presentation - TBC
14.07-14.13 Poster presentation - TBC
14.14-14.20 Poster presentation - TBC
14.21-14.27 Poster presentation - TBC
14.28-14.34 Poster presentation- TBC
14.35 Award for best poster
14.40-15.10 TEA, EXHIBITIONS AND POSTERS
Prevention and epidemic control (4) – Chair: Dr Brenda Kwambana-Adams, Malawi Liverpool Wellcome Trust
15.10-15.35 Pneumococcal vaccination in the UK: Current and future perspectives - Professor David Goldblatt, UCL
15.35- 16.50 Panel discussion on: What are the opportunities for increasing access to pneumococcal vaccines?
- 15.35-15.45 Overcoming barriers to PCV introduction in Middle income and GAVI transitioning countries - Professor Fiona Russell, Murdoch Children’s Research Institute and The University of Melbourne
- 15.45-15.55 PCV roll out in the African region: barriers and opportunities - Professor Martin Antonio, MRC Unit The Gambia
- 15.55-16.05 Use of reduced dose PCV schedules to prevent pneumococcal infection - Professor Stefan Flasche, London School of Hygiene & Tropical Medicine
- 16.05-16.25 Is fractional dosing an effective and affordable approach to protecting wider populations against IPD?
- Results of cluster RCT of mass campaigns of fractional dose PCV in children aged 1-9 in Niger - Dr Matt Coldiron, MSF
- Results of individual RCT of fractional dose PCV in infants in Kenya- Dr Katherine Gallagher, LSHTM and The KEMRI-Wellcome Trust Research Programme
- 16.25-16.50 Discussion and Q&A after all panellists have presented
16.50-17.00 Close